TCIIS
VRTX icon

TIAA-CREF Individual & Institutional Services’s Vertex Pharmaceuticals VRTX Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Sell
3,946
-116
-3% -$51.4K 0.01% 265
2026
Q1 		$1.81M Buy
+4,062
New +$1.89M 0.01% 260

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's VRTX Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services reduced its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q2 2026, selling an estimated $51.4K and leaving 3,946 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #265.

TIAA-CREF Individual & Institutional Services first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • TIAA-CREF Individual & Institutional Services held 3,946 shares of Vertex Pharmaceuticals worth $1.96M as of Q2 2026.
  • TIAA-CREF Individual & Institutional Services sold 116 Vertex Pharmaceuticals shares in Q2 2026, an estimated $51.4K.
  • Vertex Pharmaceuticals made up 0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #265 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.